These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2953525)
1. Lack of effect of atrial natriuretic peptide on vasopressin release. Ogawa K; Arnolda LF; Woodcock EA; Hiwatari M; Johnston CI Clin Sci (Lond); 1987 May; 72(5):525-30. PubMed ID: 2953525 [TBL] [Abstract][Full Text] [Related]
2. Rebound increase in plasma renin and vasopressin following graded infusions of atrial natriuretic peptide in man. Williams TD; Walsh KP; Pitts E; Sutton R; Lightman SL J Endocrinol Invest; 1988 Jan; 11(1):31-5. PubMed ID: 2966190 [TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats. Ogawa K; Henry MA; Tange J; Woodcock EA; Johnston CI Kidney Int; 1987 Mar; 31(3):760-5. PubMed ID: 2952831 [TBL] [Abstract][Full Text] [Related]
4. Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats. Shirakami G; Itoh H; Suga S; Komatsu Y; Hama N; Mori K; Nakao K Neurosci Lett; 1993 Sep; 159(1-2):25-8. PubMed ID: 8264972 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans. Williams TD; Walsh KP; Lightman SL; Sutton R Am J Physiol; 1988 Sep; 255(3 Pt 2):R368-72. PubMed ID: 2970806 [TBL] [Abstract][Full Text] [Related]
6. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation. Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777 [TBL] [Abstract][Full Text] [Related]
7. Central ANP attenuates pressor responses to central AVP in WKY and SHR. Stepniakowski K; Budzikowski A; Lon S; Szczepanska-Sadowska E Brain Res Bull; 1991 Aug; 27(2):247-9. PubMed ID: 1835898 [TBL] [Abstract][Full Text] [Related]
9. Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis. Nakajima S; Suzuki H; Kageyama Y; Takita T; Saruta T Acta Endocrinol (Copenh); 1988 Oct; 119(2):257-62. PubMed ID: 2972150 [TBL] [Abstract][Full Text] [Related]
10. Inefficiency of intracerebroventricular ANP to alter haemodynamic, plasma vasopressin and renin responses to haemorrhage in sheep. Gunnarsson U; Rundgren M Acta Physiol Scand; 1994 Apr; 150(4):441-7. PubMed ID: 8036912 [TBL] [Abstract][Full Text] [Related]
11. Effect of vasopressin and V1 receptors blockade on hypotensive action of ANP in normotensive (WKY) and spontaneously hypertensive rats. Lapiński M; Stepniakowski K; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E J Physiol Pharmacol; 1992 Mar; 43(1):65-78. PubMed ID: 1450435 [TBL] [Abstract][Full Text] [Related]
12. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats. Stepniakowski K; Budzikowski A; Loń S; Szczepańska-Sadowska E J Auton Nerv Syst; 1994 Apr; 47(1-2):33-43. PubMed ID: 8188982 [TBL] [Abstract][Full Text] [Related]
13. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin. Abu-Amarah I; Balment RJ Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700 [TBL] [Abstract][Full Text] [Related]
14. Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits. Kallaras C; Angelopoulos N; Apostolakis M; Bountzioukas S; Guiba-Tziampiri O; Kontoleon-Vakalopoulou H; Mavroudis K J Endocrinol Invest; 1998 Apr; 21(4):200-10. PubMed ID: 9624593 [TBL] [Abstract][Full Text] [Related]
15. Central effects of antiserum against human atrial natriuretic polypeptide on water and electrolyte metabolism and plasma arginine-8-vasopressin level in conscious rats. Laczi F; Szabó G; Jójárt I; Vecsernyés M; Csáti S; Kovács GL; Szarvas F; Telegdy G Neuropeptides; 1991 Jul; 19(3):183-7. PubMed ID: 1832749 [TBL] [Abstract][Full Text] [Related]
16. The role of GABA in the central regulation of AVP and ANP release and blood pressure due to angiotensin and carbachol, and central GABA release due to blood pressure changes. Kimura T; Funyu T; Ohta M; Yamamoto T; Ota K; Shoji M; Inoue M; Sato K; Abe K J Auton Nerv Syst; 1994 Dec; 50(1):21-9. PubMed ID: 7844311 [TBL] [Abstract][Full Text] [Related]
17. Left heart and arterial baroreceptors interact in control of plasma vasopressin, renin, and cortisol in awake dogs. Andersen JL; Andersen LJ; Thrasher TN; Keil LC; Ramsay DJ Am J Physiol; 1994 Mar; 266(3 Pt 2):R879-88. PubMed ID: 8160884 [TBL] [Abstract][Full Text] [Related]
18. Increasing atrial pressure during cardiac tamponade does not elevate plasma levels of the peptide ANP in conscious dogs. Klopfenstein HS; Mathias DW; Bernath GA; Cogswell TL J Physiol; 1990 Feb; 421():309-19. PubMed ID: 2140860 [TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat. Poole CJ; Carter DA; Vallejo M; Lightman SL J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195 [TBL] [Abstract][Full Text] [Related]
20. Effects of centrally administered atrial natriuretic peptide on renal functions. Shoji M; Kimura T; Matsui K; Ota K; Iitake K; Inoue M; Yasujima M; Abe K; Yoshinaga K Acta Endocrinol (Copenh); 1987 Aug; 115(4):433-40. PubMed ID: 2957880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]